PION inhibitors are a class of chemical compounds that specifically target the PION (Proteasome Inhibitor of Oncoprotein) protein, which is involved in regulating proteasome activity and protein degradation processes within cells. PION is known to play a key role in controlling the stability and turnover of various intracellular proteins by influencing their ubiquitination and subsequent degradation via the proteasome pathway. This regulation is crucial for maintaining protein homeostasis, or proteostasis, within the cell, affecting a wide range of cellular activities including cell cycle regulation, signal transduction, and response to stress. Inhibiting PION can lead to disruptions in these processes, allowing researchers to study the effects of altered proteasomal degradation and the subsequent buildup of specific proteins within the cell.
In research, PION inhibitors are utilized to explore the fine-tuning of proteasome activity and how it influences cellular pathways that are sensitive to protein degradation. These inhibitors can be used to modulate the degradation rates of specific proteins, allowing scientists to study how the accumulation of certain proteins affects cellular function, from gene expression to metabolic processes. Furthermore, PION inhibitors offer insights into the dynamics of protein quality control mechanisms, particularly how cells identify and degrade misfolded or damaged proteins. By understanding the role of PION in regulating these processes, researchers can gain a deeper understanding of the cellular mechanisms that underpin protein homeostasis, proteasomal regulation, and the consequences of dysregulated protein degradation. This can lead to broader discoveries related to cellular stress responses and protein aggregate formation under various conditions.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
Gamma-secretase inhibitor, which can indirectly reduce the effect of GSAP on beta-amyloid production. | ||||||
Semagacestat | 425386-60-3 | sc-364614 sc-364614A | 10 mg 50 mg | $350.00 $1200.00 | 1 | |
Notch-sparing gamma-secretase inhibitor, can indirectly affect GSAP's role in amyloid precursor protein processing. | ||||||
BMS-708163 | 1146699-66-2 | sc-364444 sc-364444A | 10 mg 50 mg | $480.00 $1455.00 | 1 | |
Designed to inhibit gamma-secretase, can reduce GSAP-related beta-amyloid production indirectly. | ||||||
Flurbiprofen | 5104-49-4 | sc-202158 sc-202158A | 100 mg 1 g | $70.00 $106.00 | ||
Modulator of gamma-secretase, can influence GSAP's activity on beta-amyloid cleavage indirectly. | ||||||
LY411575 | 209984-57-6 | sc-364529 sc-364529A | 10 mg 50 mg | $198.00 $473.00 | 6 | |
Potent gamma-secretase inhibitor, can indirectly inhibit the pathway involving GSAP. | ||||||
PF-3084014 | 1290543-63-3 | sc-507501 | 5 mg | $130.00 | ||
A gamma-secretase inhibitor, can indirectly impact GSAP's modulation of the enzyme complex. | ||||||